Dr. Dirk J. Van Der Windt, MD

Dr. Van Der Windt practices at MUSC Physicians in Mount Pleasant, South Carolina.

Dr. Van Der Windt's NPI, 1578825055, was assigned on June 12, 2012. Dr. Van Der Windt holds South Carolina license 87668.

Dr. Van Der Windt's primary practice is MUSC Physicians, at 1208 2 Island Ct, Mount Pleasant, SC 29466 in Charleston County. The practice phone is (803) 286-4666.

Dr. Van Der Windt's primary practice is MUSC Physicians in Mount Pleasant, South Carolina. Dr. Van Der Windt is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Van Der Windt to 2 more group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Der Windt practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Van Der Windt's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Van Der Windt's licenses on file in 3 states: South Carolina, Michigan and Pennsylvania.

CMS data shows 214 Medicare services from Dr. Van Der Windt across 5 procedure codes in 2024, for 100 Medicare patients. Medicare paid $45,683 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 100 Medicare patients who saw Dr. Van Der Windt in 2024. The largest group is under 65, with 58 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 33% are also on Medicaid. Their average risk score is 7.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Van Der Windt's median patient age at 58, with 49% women.

In 2024, Dr. Van Der Windt wrote 661 Medicare Part D claims for 111 patients. 94% of them were for generic drugs. CMS names the drug for 484 of them, across 12 drugs with 11 or more claims each, at $37,915 in total drug cost. In 2023, CMS named 505 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Van Der Windt for performance year 2024, reported as part of a group. Dr. Van Der Windt accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 30 papers to Dr. Van Der Windt, published from 2011 to 2023. 2019 was the busiest year, with 4. The most frequent topics are Swine, Graft Rejection and Immunosuppressive Agents. Dr. Van Der Windt has published most often in Hepatology. Dr. Van Der Windt's most frequent co-authors are Allan Tsung, MD, Samer T. Tohme, MD and Burcin Ekser, MD, PhD.

CMS Open Payments shows 14 general payments to Dr. Van Der Windt from 3 drug and device companies from 2022 to 2025. Education make up the largest share, 72% of the total. Intuitive Surgical, Inc. paid the most, $7,110.